SCHEMBL4328210

SCHEMBL4328210

Cc1nc2cc([N+](=O)[O-])ccc2[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
TDP1 Q9NUW8 1/20 0.51
MAPT P10636 6/20 0.51
NPBWR1 P48145 5/20 0.51
RAB9A P51151 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
NPC1 O15118 2/20 0.51
HTT P42858 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
NFKB1 P19838 1/20 0.51
MAPK1 P28482 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
POLB P06746 2/20 0.50
GRIA1 P42261 1/20 0.50
GRIA2 P42262 1/20 0.50
GRIA3 P42263 1/20 0.50
GRIA4 P48058 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4328218 0.86 ALDH1A1 (0.69) ALDH1A1TDP1MAPTNPBWR1RAB9A
SCHEMBL30806414 0.84 GRIA1 (0.57) ALDH1A1TDP1MAPTNPBWR1RAB9A
SCHEMBL18758065 0.83 ALDH1A1 (0.58) ALDH1A1TDP1MAPTNPBWR1RAB9A
SCHEMBL2711226 0.83 ALDH1A1 (0.58) ALDH1A1TDP1MAPTNPBWR1RAB9A
SCHEMBL594032 0.81 ALDH1A1 (0.56) ALDH1A1TDP1MAPTNPBWR1RAB9A
SCHEMBL1541188 0.81 ALDH1A1 (0.56) ALDH1A1TDP1MAPTNPBWR1RAB9A
SCHEMBL27567547 0.81 ALDH1A1 (0.56) ALDH1A1TDP1MAPTNPBWR1RAB9A
SCHEMBL31536798 0.81 ALDH1A1 (0.56) ALDH1A1TDP1MAPTNPBWR1RAB9A
SCHEMBL8260455 0.81 ALDH1A1 (0.56) ALDH1A1TDP1MAPTNPBWR1RAB9A
SCHEMBL833508 0.81 ALDH1A1 (0.77) ALDH1A1TDP1MAPTNPBWR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115976586-A Positive and negative pulse electrolytic nickel-tungsten alloy solution, preparation method, electroplating method and nickel-tungsten alloy coating 昆山一鼎工业科技有限公司 2023-04-18 CN claimed
CN-107118203-B Flavoazolol compound and preparation method thereof 盐城师范学院 2020-02-21 CN claimed
CN-107118203-A Flavones azoles alcohol compound and preparation method thereof 盐城师范学院 2017-09-01 CN claimed
CN-104086534-B Quinolinones azoles alcohol compound and its preparation method and application 西南大学 2016-07-06 CN claimed
CN-101419394-A High-sensitivity emulsion of photothermographic material, and preparation method and application thereof CHINESE ACAD TECH INST PHYSICS (CN) 2009-04-29 CN claimed
WO-2007110755-A1 PROPHYLAXIS OR TREATMENT OF CARDIOVASCULAR INFLAMMATION MEDICAL THERAPIES LIMITED (AU) 2007-10-04 WO claimed
WO-2007109845-A1 PROPHYLAXIS OR TREATMENT OF DIABETES MEDICAL THERAPIES LIMITED (AU) 2007-10-04 WO claimed
WO-2007026240-A1 SUNSCREEN AND COSMETIC COMPOSITIONS FOR PROPHYLAXIS OR TREATMENT OF SKIN CANCERS MEDICAL THERAPIES LIMITED (AU) 2007-03-08 WO claimed
WO-2006099685-A1 METHOD FOR THE PROPHYLAXIS OR TREATMENT OF CARCINOMAS MEDICAL THERAPIES LIMITED (AU) 2006-09-28 WO claimed
CN-1436317-A Mixtures of organic silver salts in color photothermographic systems EASTMAN KODAK CO (US) 2003-08-13 CN claimed
US-6576414-B1 PKsp of said first organic silver salt is at least 0.5 lower than the pKsp of said second silver salt; high speed, storage stable EASTMAN KODAK COMPANY 2003-06-10 US claimed
US-6548236-B1 The dye-providing couplers in the multilayers being different in hue, forming at least three dye images of different visible or non-visible colors EASTMAN KODAK COMPANY 2003-04-15 US claimed
EP-1299769-A1 MIXTURES OF ORGANIC SILVER SALTS IN COLOR PHOTOTHERMOGRAPHIC SYSTEMS EASTMAN KODAK COMPANY (US) 2003-04-09 EP claimed
US-6426181-B2 THE SECOND SILVER SALT IS A THERMAL FOG INHIBITOR THAT PREVENTS DESORPTION OF SENSITIZING DYES FROM THE IMAGING SILVER HALIDE GRAINS AND IS PREFERABLY A MERCAPTO-HETEROCYCLIC COMPOUND EASTMAN KODAK COMPANY 2002-07-30 US claimed
US-20020015928-A1 Mixtures of organic silver salts in color photothermographic systems IRVING LYN M (US) 2002-02-07 US claimed
WO-2001096949-A1 MIXTURES OF ORGANIC SILVER SALTS IN COLOR PHOTOTHERMOGRAPHIC SYSTEMS EASTMAN KODAK COMPANY (US) 2001-12-20 WO claimed
JP-6048942-A None JP disclosed
US-12410142-B2 Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof XIAMEN VIVOHEALTHS TECHNOLOGY CO., LTD. (CN) 2025-09-09 US disclosed
US-4680255-A Emulsions and photographic elements containing silver halide grains having tetrahexahedral crystal faces EASTMAN KODAK COMPANY (US) 1987-07-14 US disclosed
US-4209418-A CLEANING SOLUTIONS FOR METAL INDUSTRIAL EQUIPMENT UNION CARBIDE CORPORATION (US) 1980-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12410142-B2 Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof ALDOA, IDE, ACAT1 ALDH1A1 137/4885TDP1 1446/4885MAPT 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.